Skip to main content
Clinical Trials/CTRI/2020/12/030007
CTRI/2020/12/030007
Not yet recruiting
Phase 4

Randomised controlled trial to study the efficacy and safety of low level light therapy and topical 5% minoxidil in the management of androgenetic alopecia in males

AFMRC0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: L649- Androgenic alopecia, unspecified
Sponsor
AFMRC
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
AFMRC

Eligibility Criteria

Inclusion Criteria

  • Grade 2\-5 Norwood \- Hamilton classification

Exclusion Criteria

  • 1\. use of finasteride or dutasteride within last 6 months
  • 2\. Topical hair growth agents within last 3 months
  • 3, History of hair transplantation
  • 4\. Systemic disease affecting scalp

Outcomes

Primary Outcomes

Not specified

Similar Trials